NNBXF Nanobiotix S.A.
Price Chart
Executive Summary
Nanobiotix filed a routine 6-K with a press release disclosing its share count and voting rights as of May 31, 2026. The filing shows 50,807,903 shares outstanding and 54,282,740 exercisable voting rights. This is a standard monthly disclosure with no material financial or operational news.
Actionable Insight
This filing contains no new material information. The share count reflects recent capital raises (424B5 filings from May 2026). Monitor upcoming clinical catalysts (NANORAY-312 data) and any further dilution events for trading direction.
Key Facts
- Shares outstanding as of May 31, 2026: 50,807,903
- Total theoretical voting rights: 54,304,858
- Total exercisable voting rights: 54,282,740
- Filing is a routine voting rights and share capital disclosure under French regulations
Financial Impact
No financial impact — routine disclosure of share count and voting rights.
Risk Factors
- Recent capital raises (~4.5% dilution from May 22 offering) are already reflected in share count
- No new operational or clinical updates in this filing
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-003942 |
| Document: f6k_060526.htm | 0001171843-26-003942 |
| Document: 0001171843-26-003942-index-headers.html | 0001171843-26-003942 |
| Document: 0001171843-26-003942-index.html | 0001171843-26-003942 |
| Document: 0001171843-26-003942.txt | 0001171843-26-003942 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
4d ago
|
6-K
| — | awaiting T+20 | — | — |
|
Jun 2, 2026
7d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 26, 2026
14d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 26, 2026
14d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 22, 2026
18d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 22, 2026
18d ago
|
424B5
| — | awaiting T+20 | — | — |
|
May 21, 2026
19d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 21, 2026
19d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 20, 2026
20d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 20, 2026
20d ago
|
424B5
| — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access